(Hypertension. 2002;39:310.)
© 2002 American Heart Association, Inc.
Novartis Lecture |
From the Department of Medicine, Harvard Medical School, Brigham and Womens Hospital, Boston, Mass; and Physiological Genomics, American Physiological Society, Bethesda, Md.
Correspondence to Victor J. Dzau, Brigham and Womens Hospital, Department of Medicine, 75 Francis Street Suite 230, Boston, MA 02115. E-mail vdzau{at}partners.org
In this article we delineate the directions in which the study of physiology will take as it becomes integrated with genomics. We also provide specific examples of the ways in which physiological genomics may be applied to study the complex genetics of hypertension and cardiovascular disease.
Key Words: genetics blood pressure hypertension, essential hypertension, genetic
This article has been cited by other articles:
![]() |
P. Sinnayah, T. E. Lindley, P. D. Staber, B. L. Davidson, M. D. Cassell, and R. L. Davisson Targeted viral delivery of Cre recombinase induces conditional gene deletion in cardiovascular circuits of the mouse brain Physiol Genomics, June 17, 2004; 18(1): 25 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ueno, J. Tremblay, J. Kunes, J. Zicha, Z. Dobesova, Z. Pausova, A. Y. Deng, Y.-L. Sun, H. J. Jacob, and P. Hamet Rat model of familial combined hyperlipidemia as a result of comparative mapping Physiol Genomics, March 12, 2004; 17(1): 38 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Davisson Physiological genomic analysis of the brain renin-angiotensin system Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R498 - R511. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |